RareDiseasePlatform (RDPlatform)
is a three-year support action project of the European Union’s Seventh Framework Programme (HEALTH-F2-2008-201230), which began in May 2008.

The main goal is to create a set of tools for European researchers working in the field of rare diseases, intended to facilitate collaborations between academic teams, SMEs and major companies, and to facilitate access to technological expertise and key research resources.

These tools will help the experts, researchers and companies to identify each other and to work together with the ultimate goal of providing diagnostic tools and medical products as quickly as possible.

The information collected and disseminated during the development of this project will provide funding agencies with a clear view of what is currently funded at the national and international levels, which could be used as a fundation to target future calls for proposals.

RDPlatform
is an international initiative bringing together organisations from 13 European countries. It was conceived to address unmet needs of the European rare disease research community, that were identified during a previous project, the FP6 OrphanPlatform project.

The expected output of the RDPlatform project is:
  • To facilitate potential partnerships between research teams, between academic researchers and SMEs, between SMEs, between investment funds and SMEs and even between SMEs, and larger private companies.
  • To significantly contribute to the market transfer of innovative therapeutics, medical devices and diagnostic tools
  • To accelerate the research process on rare diseases by providing information to the rare disease research community on: databases, biobanks, patient registries, technology platforms and academic and industrial know-how.
  • To give value to existing technology platforms, databases and biobanks by facilitating identification of their facilities.
  • To provide decision makers and the community with a clear view of what is currently funded at the national and international levels in the field of RD.
  • To provide a tool for business intelligence in the field of diagnostic tools, medical devices and orphan medicinal products for RD.